home / stock / nrbo / nrbo news


NRBO News and Press, NeuroBo Pharmaceuticals Inc. From 09/10/21

Stock Information

Company Name: NeuroBo Pharmaceuticals Inc.
Stock Symbol: NRBO
Market: NASDAQ
Website: neurobopharma.com

Menu

NRBO NRBO Quote NRBO Short NRBO News NRBO Articles NRBO Message Board
Get NRBO Alerts

News, Short Squeeze, Breakout and More Instantly...

NRBO - 7 Biotech Stocks to Buy That Have Millionaire-Maker Potential

InvestorPlace - Stock Market News, Stock Advice & Trading Tips While the term “technology” often brings to mind the broader digitalization movement, tech actually has the most potential in healthcare. Thanks to groundbreaking innovations, we now know much more about the h...

NRBO - Innate Pharma, Tiziana Life Sciences leads healthcare gainers; Assembly Biosciences, Phreesia among major losers

Gainers: Innate Pharma (NASDAQ:IPHA) +32%, Tiziana Life Sciences (NASDAQ:TLSA) +16%, Verrica Pharmaceuticals (NASDAQ:VRCA) +12%, NeuroBo Pharmaceuticals (NASDAQ:NRBO) +12%, Scopus BioPharma (NASDAQ:SCPS) +11%. Losers: Assembly Biosciences (NASDAQ:ASMB) ...

NRBO - DQ, BTBT and GOTU among pre market gainers

Plus Therapeutics (NASDAQ:PSTV) +22% on manufacturing deal for Rhenium-186 NanoLiposome Innate Pharma (NASDAQ:IPHA) +17% Monalizumab and ANKET™ data will be presented at ESMO 2021 virtual Congress ChargePoint Holdings (NYSE:CHPT) +16% on Q2 earnings. Tiziana Life Science...

NRBO - NeuroBo Pharmaceuticals EPS misses by $0.03

NeuroBo Pharmaceuticals (NASDAQ:NRBO): Q2 GAAP EPS of -$0.18 misses by $0.03. Cash and Cash Equivalents were $9.5 million as of June 30, 2021, compared with $10.1 million as of December 31, 2020.  Press Release For further details see: NeuroBo Pharmaceuticals EPS misses by $0.03

NRBO - NeuroBo Pharmaceuticals Reports Second Quarter 2021 Financial Results

NeuroBo Pharmaceuticals Reports Second Quarter 2021 Financial Results PR Newswire BOSTON , Aug. 16, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal ...

NRBO - Seres Therapeutics, IAMGOLD, PBF Energy among premarket losers' pack

Seres Therapeutics (MCRB) -57% after mid-stage ulcerative colitis study fails main goal.Jupiter Wellness (JUPW) -24% after raises $32.5M capital via stock and warrants offering.TRACON Pharmaceuticals (TCON) -23% after securing $15M capital raise.NETGEAR (NTGR)&#x...

NRBO - Chembio Diagnostics, NeuroMetrix leads healthcare gainers; NeuroBo Pharmaceuticals, Healthcare Services among major losers

Gainers: Chembio Diagnostics (CEMI) +195%, NeuroMetrix (NURO) +143%, TRxADE HEALTH (MEDS) +40%, TransCode Therapeutics (RNAZ) +24%, Cassava Sciences (SAVA) +20%.Losers: NeuroBo Pharmaceuticals (NRBO) -19%, Healthcare Services (HCSG) -11%, ...

NRBO - Ardelyx, Aehr Test Systems, NeuroBo Pharmaceuticals among premarket losers' pack

Staffing 360 Solutions, Inc. (STAF) -19% after pricing $7.58M registered direct offering.NeuroBo Pharmaceuticals, Inc. (NRBO) -13%.Nova LifeStyle, Inc. (NVFY) 2%.Aehr Test Systems (AEHR) -7%.Ardelyx, Inc. (ARDX) -6%.TD Holdings, Inc. (GLG) -5%. For further details see: Ardelyx...

NRBO - 3 Biotech Penny Stocks That You Need to Know About In 2021

Best Biotech Penny Stocks to Watch in July 2021 Biotech penny stocks remain some of the hottest stocks of the year so far. While there are hundreds of penny stocks in the biotech industry to choose from, only a handful have a lot to offer investors of all types. To understand which,...

NRBO - MTSL, CEMI, OMIC amog midday movers

Gainers: NeuroMetrix (NURO) +161%.NeuroBo Pharmaceuticals (NRBO) +45%.LSB Industries (LXU) +35%.Staffing 360 Solutions (STAF) +24%.Endo International plc (ENDP) +23%.Pop Culture Group (CPOP) +23%.Immunome (IMNM) +19%.Ideal Power (IPWR) +19%.Femasys (FEMY) +16HCA Healthcare (HCA) +15%.Los...

Previous 10 Next 10